Myelofibrosis Models: Literature Review and Own Data
Background & Aims. Chronic myeloproliferative disorders typically develop during a long latent period, and it complicates the study of the mechanism of its pathogenesis. Observations from the clinical practice should be confirmed by experiments. The mechanisms of oncological transformation relat...
Saved in:
| Main Authors: | AA Silyutina, II Gin, NM Matyukhina, EN Balayan, PA Butylin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Practical Medicine Publishing House
2017-01-01
|
| Series: | Клиническая онкогематология |
| Subjects: | |
| Online Access: | http://bloodjournal.ru/wp-content/uploads/2017/01/10-1.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study
by: O. Yu. Vinogradova, et al.
Published: (2024-09-01) -
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
by: O. Yu. Vinogradova, et al.
Published: (2023-12-01) -
Possibilities of targeted therapy for myelofibrosis: Moscow experience
by: O. Yu. Vinogradova, et al.
Published: (2022-11-01) -
Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy
by: O. Yu. Vinogradova, et al.
Published: (2025-03-01) -
Informative Value of Combination of Molecular Genetic and Cytogenetic Diagnostic Methods in Myelofibrosis
by: Lozynskyy R., et al.
Published: (2016-07-01)